Blog: News
Access official press releases and corporate updates from PYFA. Stay informed on our latest business milestones, strategic partnerships, and developments across Indonesia and Asia-Pacific.
PYFA Reports Q3 2026 Financial Results: Revenue Grows 17.2%, EBITDA Surges to IDR 239.9 Billion, and Operating Loss Narrows by 91.5%
Proven Excellence in Global Contract and Toll Manufacturing Services, Pyridam Farma (PYFA) Named Best Pharmaceutical CDMO & Global Expansion Leader 2026
Beware the Dangers of Forced Running: PYFA Expert Highlights Risks of Knee Joint Damage in Individuals with Obesity
Surging Running Trend Prompts Pyridam Farma (PYFA) to Urge Indonesian Runners to Protect Joints and Bones Early On
Pyridam Farma (PYFA) Expands Access to Lipid Disorder Therapies, Supporting Cardiovascular Risk Factor Management
PYFA Distributes Tens of Thousands of Vitamin Supplements to Support Health Recovery for Disaster Victims in NTT and Kalimantan
Three Months Post-Launch: PYFAESTHETIC’s Collost Native Collagen Surpasses 2,500 Treatments
Pyridam Farma (PYFA) Excels in CDMO Services, Accelerates Expansion of Capacity and Capabilities
With Indonesian Pharmacists Association, PYFA Advances National Pharmaceutical Resilience
